富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/06 | 1,587 | 1,715 | 1,576 | 1,707 | +120 | +7.6% | 468,900 |
| 2023/12/05 | 1,540 | 1,595 | 1,540 | 1,587 | +50 | +3.3% | 267,900 |
| 2023/12/04 | 1,530 | 1,544 | 1,498 | 1,537 | +1 | +0.1% | 121,800 |
| 2023/12/01 | 1,562 | 1,586 | 1,529 | 1,536 | -24 | -1.5% | 168,000 |
| 2023/11/30 | 1,518 | 1,564 | 1,512 | 1,560 | +43 | +2.8% | 285,700 |
| 2023/11/29 | 1,524 | 1,532 | 1,483 | 1,517 | -2 | -0.1% | 401,200 |
| 2023/11/28 | 1,517 | 1,566 | 1,482 | 1,519 | +92 | +6.4% | 1,115,800 |
| 2023/11/27 | 1,453 | 1,453 | 1,419 | 1,427 | -9 | -0.6% | 92,000 |
| 2023/11/24 | 1,447 | 1,447 | 1,428 | 1,436 | -11 | -0.8% | 92,600 |
| 2023/11/22 | 1,460 | 1,479 | 1,443 | 1,447 | -13 | -0.9% | 109,000 |
| 2023/11/21 | 1,434 | 1,467 | 1,425 | 1,460 | +46 | +3.3% | 157,000 |
| 2023/11/20 | 1,444 | 1,451 | 1,413 | 1,414 | -27 | -1.9% | 101,100 |
| 2023/11/17 | 1,384 | 1,441 | 1,384 | 1,441 | +42 | +3% | 256,000 |
| 2023/11/16 | 1,425 | 1,429 | 1,394 | 1,399 | -36 | -2.5% | 213,900 |
| 2023/11/15 | 1,437 | 1,456 | 1,416 | 1,435 | -7 | -0.5% | 182,800 |
| 2023/11/14 | 1,460 | 1,461 | 1,418 | 1,442 | -18 | -1.2% | 357,300 |
| 2023/11/13 | 1,435 | 1,490 | 1,420 | 1,460 | +67 | +4.8% | 732,200 |
| 2023/11/10 | 1,317 | 1,393 | 1,317 | 1,393 | +235 | +20.3% | 1,142,900 |
| 2023/11/09 | 1,163 | 1,171 | 1,147 | 1,158 | +5 | +0.4% | 92,700 |
| 2023/11/08 | 1,165 | 1,167 | 1,143 | 1,153 | -18 | -1.5% | 79,700 |
| 2023/11/07 | 1,171 | 1,176 | 1,163 | 1,171 | +18 | +1.6% | 52,000 |
| 2023/11/06 | 1,168 | 1,173 | 1,153 | 1,153 | -16 | -1.4% | 53,700 |
| 2023/11/02 | 1,182 | 1,182 | 1,120 | 1,169 | -5 | -0.4% | 70,900 |
| 2023/11/01 | 1,176 | 1,179 | 1,166 | 1,174 | +9 | +0.8% | 38,500 |
| 2023/10/31 | 1,160 | 1,166 | 1,136 | 1,165 | +32 | +2.8% | 63,000 |
| 2023/10/30 | 1,161 | 1,162 | 1,128 | 1,133 | -27 | -2.3% | 55,600 |
| 2023/10/27 | 1,146 | 1,162 | 1,140 | 1,160 | +24 | +2.1% | 47,900 |
| 2023/10/26 | 1,140 | 1,161 | 1,133 | 1,136 | ±0 | ±0% | 43,400 |
| 2023/10/25 | 1,130 | 1,147 | 1,126 | 1,136 | -1 | -0.1% | 149,100 |
| 2023/10/24 | 1,128 | 1,141 | 1,114 | 1,137 | +1 | +0.1% | 173,000 |
| 2023/10/23 | 1,141 | 1,146 | 1,136 | 1,136 | -16 | -1.4% | 217,100 |
| 2023/10/20 | 1,148 | 1,156 | 1,141 | 1,152 | +6 | +0.5% | 20,800 |
| 2023/10/19 | 1,142 | 1,160 | 1,140 | 1,146 | +4 | +0.4% | 40,100 |
| 2023/10/18 | 1,141 | 1,148 | 1,132 | 1,142 | +2 | +0.2% | 44,000 |
| 2023/10/17 | 1,150 | 1,156 | 1,132 | 1,140 | ±0 | ±0% | 33,800 |
| 2023/10/16 | 1,153 | 1,158 | 1,137 | 1,140 | -22 | -1.9% | 44,200 |
| 2023/10/13 | 1,178 | 1,186 | 1,157 | 1,162 | -28 | -2.4% | 53,300 |
| 2023/10/12 | 1,191 | 1,194 | 1,178 | 1,190 | -4 | -0.3% | 33,300 |
| 2023/10/11 | 1,199 | 1,207 | 1,190 | 1,194 | -5 | -0.4% | 57,600 |
| 2023/10/10 | 1,180 | 1,199 | 1,177 | 1,199 | +67 | +5.9% | 102,200 |
| 2023/10/06 | 1,125 | 1,141 | 1,125 | 1,132 | +2 | +0.2% | 41,700 |
| 2023/10/05 | 1,121 | 1,132 | 1,115 | 1,130 | +11 | +1% | 48,600 |
| 2023/10/04 | 1,143 | 1,143 | 1,113 | 1,119 | -16 | -1.4% | 73,100 |
| 2023/10/03 | 1,148 | 1,148 | 1,133 | 1,135 | -9 | -0.8% | 40,800 |
| 2023/10/02 | 1,165 | 1,170 | 1,144 | 1,144 | -22 | -1.9% | 52,400 |
| 2023/09/29 | 1,187 | 1,190 | 1,159 | 1,166 | -23 | -1.9% | 62,300 |
| 2023/09/28 | 1,194 | 1,201 | 1,185 | 1,189 | -27 | -2.2% | 61,200 |
| 2023/09/27 | 1,196 | 1,217 | 1,186 | 1,216 | +14 | +1.2% | 82,100 |
| 2023/09/26 | 1,212 | 1,216 | 1,199 | 1,202 | -2 | -0.2% | 52,800 |
| 2023/09/25 | 1,200 | 1,205 | 1,186 | 1,204 | +15 | +1.3% | 86,700 |
101～
150
件表示中 / 6703件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 157,100円 | +19.7% | +23.1% | 2.71% | 6.18倍 | 0.93倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 74,100円 | +7.9% | -26.7% | 3.51% | 15.55倍 | 0.56倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ダイト | 252,900円 | +5.3% | -7.1% | 2.37% | 11.81倍 | 0.75倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 331,000円 | -5.1% | -21.2% | 4.83% | 10.45倍 | 2.01倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| セルソース | 151,000円 | +19.0% | -13.1% | 0.33% | 41.60倍 | 4.87倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
